The Blood Plasma market is expected to grow from USD 31.67 billion in 2019 to USD 62.82 billion by 2026 at a CAGR of 10% from 2020 to 2026.
Plasma is the fluid part of the blood. Plasma is the flexible part and makes around 55% of the blood. Plasma is the composite blend of in excess of 700 proteins and different substances which are fundamental for the proficient working of the human body. Plasma helps in controlling body temperature and pulse. It fills in as a medium for trade of proteins, supplements and hormones to the diverse parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma.
The global Blood Plasma market is segregated on the basis of Product as Immunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates, and Others. Based on Application the global Blood Plasma market is segmented in Hospitals and Clinics, Research Laboratories, and Academic Institutions.
The global Blood Plasma market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Blood Plasma market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences, and others are among the major players in the global Blood Plasma market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Blood Plasma market has been segmented as below:
Blood Plasma Market, By Product
Blood Plasma Market, By Application
Blood Plasma Market, By Region
Blood Plasma Market, By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global Blood Plasma market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Blood Plasma market share. Major industry players with significant revenue share include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences, and others.
Why to Buy this Report:
Target Audience:
The report targeted towards the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter''s Five Force Analysis
5.1 Introduction
5.2 Immunoglobulin
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Albumin
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Protease Inhibitors
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Coagulation Factor Concentrates
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Others
5.6.1 Market Overview
5.6.2 Market Size and Forecast
6.1 Introduction
6.2 Hospitals and Clinics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Research Laboratories
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Academic Institutions
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 North America
7.2.1 North America Blood Plasma, By Product
7.2.2 North America Blood Plasma, By Application
7.3 Europe
7.3.1 Europe Blood Plasma, By Product
7.3.2 Europe Blood Plasma, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Blood Plasma, By Product
7.4.2 Asia-Pacific Blood Plasma, By Application
7.5 Rest of the World
7.5.1 Rest of the World Blood Plasma, By Product
7.5.2 Rest of the World Blood Plasma, By Application
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9.1 Baxter International
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 CSL
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Grifols
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Octapharma
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 ADMA Biologics
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Cerus Corp
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Sanquin
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Shanghai Raas
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 TCS Biosciences
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
The global Blood Plasma market has been segmented as below:
Blood Plasma Market, By Product
Blood Plasma Market, By Application
Blood Plasma Market, By Region
Blood Plasma Market, By Company